Literature DB >> 11686015

Purine and pyrimidine nucleoside analogs.

W Plunkett1, V Gandhi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11686015

Source DB:  PubMed          Journal:  Cancer Chemother Biol Response Modif        ISSN： 0921-4410


× No keyword cloud information.
  15 in total

1.  Epigenetic modifiers enhance the synergistic cytotoxicity of combined nucleoside analog-DNA alkylating agents in lymphoma cell lines.

Authors:  Benigno C Valdez; Yago Nieto; David Murray; Yang Li; Guiyun Wang; Richard E Champlin; Borje S Andersson
Journal:  Exp Hematol       Date:  2012-06-09       Impact factor: 3.084

2.  ATP chemosensitivity testing of new antitumor duplex drugs linking 3`-C-ethynylycytidine (ECyd) and 2´-deoxy-5-fluorouridine (5-FdU) in comparison to standard cytostatica and combinations thereof.

Authors:  Sarah Schott; Markus Wallwiener; Beate Kootz; Harald Seeger; Tanja Fehm; Hans Neubauer
Journal:  Invest New Drugs       Date:  2009-12-09       Impact factor: 3.850

Review 3.  Interstrand crosslink inducing agents in pretransplant conditioning therapy for hematologic malignancies.

Authors:  Benigno C Valdez; Borje S Andersson
Journal:  Environ Mol Mutagen       Date:  2010-07       Impact factor: 3.216

4.  A non-natural nucleoside with combined therapeutic and diagnostic activities against leukemia.

Authors:  Edward A Motea; Irene Lee; Anthony J Berdis
Journal:  ACS Chem Biol       Date:  2012-03-13       Impact factor: 5.100

5.  The synergistic cytotoxicity of clofarabine, fludarabine and busulfan in AML cells involves ATM pathway activation and chromatin remodeling.

Authors:  Benigno C Valdez; Yang Li; David Murray; Richard E Champlin; Borje S Andersson
Journal:  Biochem Pharmacol       Date:  2010-10-08       Impact factor: 5.858

6.  Synergistic cytotoxicity of the DNA alkylating agent busulfan, nucleoside analogs and suberoylanilide hydroxamic acid in lymphoma cell lines.

Authors:  Benigno C Valdez; David Murray; Yago Nieto; Yang Li; Guiyun Wang; Richard E Champlin; Borje S Andersson
Journal:  Leuk Lymphoma       Date:  2011-12-06

7.  Cladribine, gemcitabine, busulfan, and SAHA combination as a potential pretransplant conditioning regimen for lymphomas: A preclinical study.

Authors:  Jie Ji; Benigno C Valdez; Yang Li; Yan Liu; Esmeralda C Teo; Yago Nieto; Richard E Champlin; Borje S Andersson
Journal:  Exp Hematol       Date:  2016-03-11       Impact factor: 3.084

8.  Chain termination and inhibition of mammalian poly(A) polymerase by modified ATP analogues.

Authors:  Lisa S Chen; Lei Du-Cuny; Vasupradha Vethantham; David H Hawke; James L Manley; Shuxing Zhang; Varsha Gandhi
Journal:  Biochem Pharmacol       Date:  2009-10-06       Impact factor: 5.858

9.  Inhibition of ATP synthase by chlorinated adenosine analogue.

Authors:  Lisa S Chen; Billie J Nowak; Mary L Ayres; Nancy L Krett; Steven T Rosen; Shuxing Zhang; Varsha Gandhi
Journal:  Biochem Pharmacol       Date:  2009-05-27       Impact factor: 5.858

Review 10.  Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer.

Authors:  William B Parker
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.